389 related articles for article (PubMed ID: 23057058)
1. Randomized controlled clinical study of rhPDGF-BB + β-TCP versus HA + β-TCP for the treatment of infrabony periodontal defects: clinical and radiographic results.
Thakare K; Deo V
Int J Periodontics Restorative Dent; 2012 Dec; 32(6):689-96. PubMed ID: 23057058
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.
Nevins M; Giannobile WV; McGuire MK; Kao RT; Mellonig JT; Hinrichs JE; McAllister BS; Murphy KS; McClain PK; Nevins ML; Paquette DW; Han TJ; Reddy MS; Lavin PT; Genco RJ; Lynch SE
J Periodontol; 2005 Dec; 76(12):2205-15. PubMed ID: 16332231
[TBL] [Abstract][Full Text] [Related]
3. Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and beta-tricalcium phosphate for the treatment of periodontal intraosseous defects.
Ridgway HK; Mellonig JT; Cochran DL
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):171-9. PubMed ID: 18546813
[TBL] [Abstract][Full Text] [Related]
4. Stem Cells Cultured on Beta Tricalcium Phosphate (β-TCP) in Combination with Recombinant Human Platelet-Derived Growth Factor - BB (rh-PDGF-BB) for the Treatment of Human Infrabony Defects.
Dhote R; Charde P; Bhongade M; Rao J
J Stem Cells; 2015; 10(4):243-54. PubMed ID: 27144828
[TBL] [Abstract][Full Text] [Related]
5. Single versus double flap approach in periodontal regenerative treatment.
Schincaglia GP; Hebert E; Farina R; Simonelli A; Trombelli L
J Clin Periodontol; 2015 Jun; 42(6):557-66. PubMed ID: 25924545
[TBL] [Abstract][Full Text] [Related]
6. New composite endpoints to assess efficacy in periodontal therapy clinical trials.
Lynch SE; Lavin PT; Genco RJ; Beasley WG; Wisner-Lynch LA
J Periodontol; 2006 Aug; 77(8):1314-22. PubMed ID: 16881800
[TBL] [Abstract][Full Text] [Related]
7. rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations.
McGuire MK; Kao RT; Nevins M; Lynch SE
Int J Periodontics Restorative Dent; 2006 Jun; 26(3):223-31. PubMed ID: 16836164
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial.
Peres MF; Ribeiro ED; Casarin RC; Ruiz KG; Junior FH; Sallum EA; Casati MZ
J Clin Periodontol; 2013 Mar; 40(3):252-9. PubMed ID: 23379539
[TBL] [Abstract][Full Text] [Related]
9. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
10. Treatment of human periodontal infrabony defects with hydroxyapatite + β tricalcium phosphate bone graft alone and in combination with platelet rich plasma: a randomized clinical trial.
Kaushick BT; Jayakumar ND; Padmalatha O; Varghese S
Indian J Dent Res; 2011; 22(4):505-10. PubMed ID: 22124042
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of β-tricalcium phosphate in human infrabony periodontal osseous defects: a clinical study.
Chawla K; Lamba AK; Faraz F; Tandon S
Quintessence Int; 2011 Apr; 42(4):291-300. PubMed ID: 21516274
[TBL] [Abstract][Full Text] [Related]
12. Treatment of periodontal intrabony defects using β-TCP alone or in combination with rhPDGF-BB: a randomized controlled clinical and radiographic study.
Maroo S; Murthy KR
Int J Periodontics Restorative Dent; 2014; 34(6):841-7. PubMed ID: 25411740
[TBL] [Abstract][Full Text] [Related]
13. Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.
Jayakumar A; Rajababu P; Rohini S; Butchibabu K; Naveen A; Reddy PK; Vidyasagar S; Satyanarayana D; Pavan Kumar S
J Clin Periodontol; 2011 Feb; 38(2):163-72. PubMed ID: 21133980
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of relative efficacy of β-tricalcium phosphate with and without type I resorbable collagen membrane in periodontal infrabony defects: a clinical and radiographic study.
Kishore DT; Bandiwadekar T; Padma R; Debunath S; Profulla ; Reddy A
J Contemp Dent Pract; 2013 Mar; 14(2):193-201. PubMed ID: 23811645
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of rhPDGF-BB + β-TCP and subepithelial connective tissue graft for the treatment of multiple gingival recession defects in humans.
Deshpande A; Koudale SB; Bhongade ML
Int J Periodontics Restorative Dent; 2014; 34(2):241-9. PubMed ID: 24600660
[TBL] [Abstract][Full Text] [Related]
17. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
19. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone.
Nevins M; Camelo M; Nevins ML; Schenk RK; Lynch SE
J Periodontol; 2003 Sep; 74(9):1282-92. PubMed ID: 14584860
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Clinical Trial Evaluating rh-FGF-2/β-TCP in Periodontal Defects.
Cochran DL; Oh TJ; Mills MP; Clem DS; McClain PK; Schallhorn RA; McGuire MK; Scheyer ET; Giannobile WV; Reddy MS; Abou-Arraj RV; Vassilopoulos PJ; Genco RJ; Geurs NC; Takemura A
J Dent Res; 2016 May; 95(5):523-30. PubMed ID: 26908630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]